The global sodium hyaluronate market is likely to register a CAGR of over 7.2% with an incremental growth of USD 4.9 billion during the forecast period 2022-2028.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global sodium hyaluronate market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the sodium hyaluronate industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, application, and region. The global market for sodium hyaluronate can be segmented by type: topical, injectable, others. The injectable segment captured the largest share of the market in 2021. Sodium hyaluronate market is further segmented by application: pharmaceutical, cosmetic, others. The pharmaceutical segment held the largest share of the global sodium hyaluronate market in 2021 and is anticipated to hold its share during the forecast period. Based on region, the sodium hyaluronate market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. In 2021, North America made up the largest share of revenue generated by the sodium hyaluronate market.
Market Segmentation
By type: topical, injectable, others
By application: pharmaceutical, cosmetic, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report also provides a detailed analysis of several leading sodium hyaluronate market vendors that include Allergan, Inc., Anika Therapeutics Inc., Ferring Holding SA, Fidia Farmaceutici S.p.A., Galderma S.A., Johnson & Johnson, LG Chem Ltd., Zimmer Biomet Holdings, Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global sodium hyaluronate market.
– To classify and forecast the global sodium hyaluronate market based on type, application, region.
– To identify drivers and challenges for the global sodium hyaluronate market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global sodium hyaluronate market.
– To identify and analyze the profile of leading players operating in the global sodium hyaluronate market.
Why Choose This Report
– Gain a reliable outlook of the global sodium hyaluronate market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2021 |
| Forecast Year | 2022-2028 |
| CAGR (2022-2028) | 7.24% |
| Pages | 85 |
| Key Players | Allergan Inc., Anika Therapeutics Inc., Ferring Holding SA, Fidia Farmaceutici S.p.A., Galderma S.A., Johnson & Johnson, LG Chem Ltd., Zimmer Biomet Holdings Inc. |
The global zinc citrate market, in terms of revenue, is expected to grow by 3.2 percent annually through 2030, according to the latest estimates. The top market companies profiles included…
The global hydroxylamine market is projected to expand at a CAGR of ~5.1 percent across the forecast period of 2024 – 2030, according to the latest edition of the Global…
According to the latest estimates, the global sulfone polymers market is predicted to be growing at a CAGR of over 6.6% from 2024 to 2030. Sulfone polymers are linear aromatic…
Please fill out our form and we will get back to you.
